Home > Legal Library > Advanced Search > Search Results









Join Matindale-Hubbell Connected



Search Results (637)

  
Documents on Antitrust & Trade Regulation, Technology & Science, Banking & Financial Services
 

View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLFDA Revises Draft Guidance on Brief Summary and Adequate Directions for Use in DTC Print Ads and Promotional Labeling for Prescription Drugs
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
September 1, 2015, previously published on August 2015
In a bid to give consumers better and more actionable information, the regulator revised recommendations for disclosing risk information in DTC prescription drug ads and promotional labeling in print media as it relates to the brief summary requirement and the requirement that adequate directions...

 

HTMLFDA Guidance Explains How the Agency Will Determine Whether a 510(K) Submission Should Be Accepted for Substantive Review
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
September 1, 2015, previously published on August 2015
The regulator issued guidance to go over the necessary elements and contents of a complete 510(k) submission in a bid to enhance the consistency of acceptance decisions.

 

HTMLOPDP Warns Duchesnay over Kim Kardashian’s Social Media Endorsement of Morning Sickness Drug
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
September 1, 2015, previously published on August 2015
The regulator issued a warning letter stating Kardashian’s endorsement of the company’s Diclegis pill on social media was misleading because she failed to include risk information and limitations of use.

 

HTMLCourt Prohibits FDA from Bringing Charges against Drugmaker Amarin for Promoting Fish Oil Drug for Off-Label Uses
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
September 1, 2015, previously published on August 2015
A New York federal judge granted Amarin’s bid for “preliminary relief,” allowing the drugmaker to promote its Vascepa pill for off-label use without the threat of an FDA misbranded action, as long as its communications are truthful and nonmisleading.

 

HTMLMembers of the Securities Regulator and the Enforcement Committee Issue Proposals on Dual Enforcement of Market Abuses
Philippe Goutay, Anselme Mialon; Jones Day;
Legal Alert/Article
June 26, 2015, previously published on June 2015
As previously reported, recent case law requires amending rules providing for the dual enforcement of market abuses both by the enforcement body of the securities regulator and criminal courts.

 

HTMLCourt Finds Swap Agreement and Underlying Lease Agreement Are Not Severable
Philippe Goutay, Anselme Mialon; Jones Day;
Legal Alert/Article
June 26, 2015, previously published on June 2015
In a decision dated January 20, 2015, the Paris Court of Appeal confirmed an earlier decision held by a lower court in a case involving a floating rate lease agreement and a swap contract.

 

HTMLPosition Limits and Reporting on Commodity Derivatives to Take Effect Next Month
Philippe Goutay, Anselme Mialon; Jones Day;
Legal Alert/Article
June 26, 2015, previously published on June 2015
Beyond providing for a French regime of banking separation, French Law no. 2013-672 of July 26, 2013 had sought to anticipate MiFID 2 on a number of issues. Among such issues, starting from July 1, 2015, the Autorité des Marchés Financiers ("AMF") will be empowered to impose...

 

HTMLProvisions Applying to French Branches of Non-EU Credit Institutions Are Revised
Philippe Goutay, Anselme Mialon; Jones Day;
Legal Alert/Article
June 26, 2015, previously published on June 2015
Pursuant to Article 47(1) of CRD IV, Ordinance no. 2015-558 dated May, 21, 2015 amended with immediate effect the provisions applying to French branches of non-EU credit institutions.

 

HTMLFDA Puts out Guidance to Require Submissions in ICH’s Electronic Format for Certain Pharmaceutical Product Applications Within Two Years
Scott S. Liebman; Loeb & Loeb LLP;
Legal Alert/Article
June 16, 2015, previously published on May 2015
The regulator issued guidance in accordance with the FDCA that outlines Electronic Common Technical Document (eCTD) specification requirements for submissions of new drug or biological products, requiring that all submissions be done electronically and in the ICH-developed format within the next...

 

HTMLSupreme Court Limits Antitrust Immunity for Certain State Agencies
Robert B. Craig, Aaron M. Herzig; Taft Stettinius & Hollister LLP;
Legal Alert/Article
March 25, 2015, previously published on March 2, 2015
Last week, the United States Supreme Court issued an opinion that will have a broad impact on how states regulate professions through agencies and licensing boards. In North Carolina State Board of Dental Examiners v. FTC, No. 13-534, 574 U.S. &under;&under; (2015), the court ruled that the...

 


View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>